Search
SBIA Webinar: Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs - 10/02/2020 - 10/02/2020
… -events-human-drugs/sbia-webinar-overview-guidance-industry-control-nitrosamine-impurities-human-drugs-10022020-10022020 … View Slides ABOUT …
Regulatory Best Practices for Global Access to Medicines, Including Anti-TB Medicines - 08/16/2022
… Anti-TB Medicines Day 3-Session 1 Identification and Control of Harmful Impurities in Pharmaceutical Products: Nitrosamine as an Example Mrunal A. Jaywant, PhD, PGDMM …
Pharmaceutical Quality Symposium 2021: Innovations in a Changing World - 10/26/2021
… |OPQ | CDER Pharmaceutical Quality Symposium 2021 Part 5 Control of Nitrosamine Impurities in Human Drugs Research Fueling Approvals: A Case …
Parenteral Drug Association/Food and Drug Administration Joint Conference – The Future is Now: Effective Quality Management and Robust Manufacturing - 09/14/2020 - 09/16/2020
… will also learn about hot topics such as supplier quality control, new large volume parenteral technical approaches, … tools to help strengthen deviation management, preventing nitrosamine impurities, and how regulators assess firms in times of …